Genetic polymorphisms in the egfr (R521K) and estrogen receptor (T594T) genes, EGFR and erbb-2 protein expression, and breast cancer risk in tunisia

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Reba, Ahmed ^a   Kallel, Imen ^a   Rebai, Maha ^a   Khabir, Abdelmajid ^b   Farid, Nadir R ^c  

^a CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^b HABIB BOURGUIBA HOSPITAL   (Tunisia)

^c Osancor Biotech Inc   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; PROTEIN BCL 2; EGFR PROTEIN, HUMAN; ESR1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER GRADING; CANCER RISK; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROGNOSIS; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA; BIOSYNTHESIS; BREAST TUMOR; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; COHORT STUDIES; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; TUNISIA;

EID: 68949114186     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/753683     Document Type: Article

References (29)

1. Laskin J. J., Sandler A. B., Epidermal growth factor receptor: a promising target in solid tumours Cancer Treatment Reviews 2004 30 1 1 17
2. Olayioye M. A., Neve R. M., Lane H. A., The ErbB signalling network: receptor heterodimerization in development and cancer The EMBO Journal 2000 19 3159 3167
3. Zhang W., Stoehlmacher J., Park D. J., Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer Clinical Colorectal Cancer 2005 5 2 124 131
4. Moriai T., Kobrin M. S., Hope C., Speck L., Korc M., A variant epidermal growth factor receptor exhibits altered type transforming growth factor binding and transmembrane signaling Proceedings of the National Academy of Sciences of the United States of America 1994 91 21 10217 10221
5. Allred D. C., Mohsin S. K., Harris J. R., Biological features of human premalignant breast disease Diseases of the Breast 2000 Philadelphia, Pa, USA Lippincott Williams Wilkins 355 366
6. Ascenzi P., Bocedi A., Marino M., Structure-function relationship of estrogen receptor and:impact on human health Molecular Aspects of Medicine 2006 27 4 299 402
7. Fisher B., Redmond C., Fisher E. R., Caplan R., Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06 Journal of Clinical Oncology 1988 6 7 1076 1087
8. Curran J. E., Lea R. A., Rutherford S., Weinstein S. R., Griffiths L. R., Association of estrogen receptor and glucocorticoid receptor gene polymorphisms with sporadic breast cancer International Journal of Cancer 2001 95 4 271 275
9. Pavao M., Traish A. M., Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor and Steroids 2001 66 1 1 16
10. Akisik E., Dalay N., Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk Experimental and Molecular Pathology 2004 76 3 260 263
11. Reba M., Kallel I., Charfeddine S., Hamza F., Guermazi F., Rebai A., Association of polymorphisms in oestrogen and thyroid hormone receptors with thyroid cancer risk Journal of Receptors and Signal Transduction 2009 29 113 118
12. Khabir A., Ghorbel A., Daoud J., Similar BCL-X but different BCL-2 levels in the two age groups of North African nasopharyngeal carcinomas Cancer Detection and Prevention 2003 27 4 250 255
13. Maalej A., Petit-Teixeira E., Chabchoub G., Lack of association of VDR gene polymorphisms with thyroid autoimmune disorders: familial and case/control studies Journal of Clinical Immunology 2008 28 1 21 25
14. Papadopoulou E., Simopoulos K., Tripsianis G., Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer Neoplasma 2007 54 5 365 373
15. Aifa S., Rebai A., ErbB antagonists patenting: playing chess with cancer Recent Patents on Biotechnology 2008 2 3 181 187
16. Bandrs E., Barricarte R., Cantero C., Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients Oral Oncology 2007 43 7 713 719
17. Lassman A. B., Rossi M. R., Razier J. R., Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium trials 01-03 and 00-01 Clinical Cancer Research 2005 11 21 7841 7850
18. Wang W.-S., Chen P.-M., Chiou T.-J., Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma Clinical Cancer Research 2007 13 12 3597 3604
19. Carter C. L., Allen C., Henson D. E., Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases Cancer 1989 63 1 181 187
20. Hsiao W. C., Young K. C., Lin S. L., Lin P. W., Estrogen receptor- polymorphism in a Taiwanese clinical breast cancer population: a case-control study Breast Cancer Research 2004 6 3 R180 R186
21. Shen Y., Li D.-K., Wu J., Zhang Z., Gao E., Joint effects of the CYP1A1 MspI, ER PvuII, and ER XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China Cancer Epidemiology Biomarkers and Prevention 2006 15 2 342 347
22. Slamon D. J., Clark G. M., Wong S. G., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 1987 235 4785 177 182
23. Hua W., Christianson T., Rougeot C., Rochefort H., Clinton G. M., SKOV3 ovarian carcinoma cells have functional estrogen receptor but are growth-resistant to estrogen and antiestrogens Journal of Steroid Biochemistry and Molecular Biology 1995 55 3-4 279 289
24. Hill S. M., Fuqua S. A. W., Chamness G. C., Greene G. L., McGuire W. L., Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism Cancer Research 1989 49 1 145 148
25. Gennari L., Becherini L., Masi L., Vitamin D receptor genotypes and intestinal calcium absorption in postmenopausal women Calcified Tissue International 1997 61 6 460 463
26. Ushiyama T., Ueyama H., Inoue K., Nishioka J., Ohkubo I., Hukuda S., Estrogen receptor gene polymorphism and generalized osteoarthritis Journal of Rheumatology 1998 25 1 134 137
27. Kobayashi S., Inoue S., Hosoi T., Association of bone mineral density with polymorphism of estrogen receptor gene Journal of Bone and Mineral Research 1996 11 306 311
28. Andersen T. I., Heimdal K. R., Skrede M., Tveit K., Berg K., Borresen A.-L., Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility Human Genetics 1994 94 6 665 670
29. Speer G., Cseh K., Winkler G., Takcs I., Nagy Z., Lakatos P., Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers European Journal of Cancer 2001 37 12 1463 1468